This site has just undergone scheduled maintenance in order to be moved to a new infrastructure. You shouldn’t experience any change, but do let us know (datacentre@scilifelab.se) if you think anything looks out of place.

Reply to Pandey: IgG3 allotypes, modulation of antigen binding by constant domain changes, and therapeutic applications of Fc engineering.

Izadi A, Bahnan W, Ohlin M, Nordenfelt P

Proc. Natl. Acad. Sci. U.S.A. 120 (22) e2306562120 [2023-05-30; online 2023-05-22]

Drug Discovery and Development (DDD) [Service]

PubMed 37216528

DOI 10.1073/pnas.2306562120

Crossref 10.1073/pnas.2306562120

pmc: PMC10235970


Publications 9.5.1